GNAS
Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas
Also known as: GNAS1, GNAS1_HUMAN, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5JWF2
- Gene
- GNAS
- Ensembl
- ENSG00000087460
- Chromosome
- 20
- Canonical length
- 1037 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. [provided by RefSeq, Aug 2012]
Canonical amino-acid sequenceUniProt
1037 residues, UniProt reviewed canonical sequence.
>Q5JWF2|GNAS
1 MGVRNCLYGN NMSGQRDIPP EIGEQPEQPP LEAPGAAAPG AGPSPAEEME TEPPHNEPIP
61 VENDGEACGP PEVSRPNFQV LNPAFREAGA HGSYSPPPEE AMPFEAEQPS LGGFWPTLEQ
121 PGFPSGVHAG LEAFGPALME PGAFSGARPG LGGYSPPPEE AMPFEFDQPA QRGCSQLLLQ
181 VPDLAPGGPG AAGVPGAPPE EPQALRPAKA GSRGGYSPPP EETMPFELDG EGFGDDSPPP
241 GLSRVIAQVD GSSQFAAVAA SSAVRLTPAA NAPPLWVPGA IGSPSQEAVR PPSNFTGSSP
301 WMEISGPPFE IGSAPAGVDD TPVNMDSPPI ALDGPPIKVS GAPDKRERAE RPPVEEEAAE
361 MEGAADAAEG GKVPSPGYGS PAAGAASADT AARAAPAAPA DPDSGATPED PDSGTAPADP
421 DSGAFAADPD SGAAPAAPAD PDSGAAPDAP ADPDSGAAPD APADPDAGAA PEAPAAPAAA
481 ETRAAHVAPA APDAGAPTAP AASATRAAQV RRAASAAPAS GARRKIHLRP PSPEIQAADP
541 PTPRPTRASA WRGKSESSRG RRVYYDEGVA SSDDDSSGDE SDDGTSGCLR WFQHRRNRRR
601 RKPQRNLLRN FLVQAFGGCF GRSESPQPKA SRSLKVKKVP LAEKRRQMRK EALEKRAQKR
661 AEKKRSKLID KQLQDEKMGY MCTHRLLLLG AGESGKSTIV KQMRILHVNG FNGEGGEEDP
721 QAARSNSDGE KATKVQDIKN NLKEAIETIV AAMSNLVPPV ELANPENQFR VDYILSVMNV
781 PDFDFPPEFY EHAKALWEDE GVRACYERSN EYQLIDCAQY FLDKIDVIKQ ADYVPSDQDL
841 LRCRVLTSGI FETKFQVDKV NFHMFDVGGQ RDERRKWIQC FNDVTAIIFV VASSSYNMVI
901 REDNQTNRLQ EALNLFKSIW NNRWLRTISV ILFLNKQDLL AEKVLAGKSK IEDYFPEFAR
961 YTTPEDATPE PGEDPRVTRA KYFIRDEFLR ISTASGDGRH YCYPHFTCAV DTENIRRVFN
1021 DCRDIIQRMH LRQYELLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GNAS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 3,737 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 3,737 nTPM
- hypothalamus: 3,070 nTPM
- thyroid gland: 2,932 nTPM
- salivary gland: 2,665 nTPM
- tongue: 2,362 nTPM
- skeletal muscle: 2,238 nTPM
Single-cell type
- pancreatic islet cells: 6,202 nCPM
- lactotrophs: 4,354 nCPM
- thyrotrophs: 4,260 nCPM
- somatotrophs: 4,132 nCPM
- platelets: 3,231 nCPM
- late spermatids: 2,986 nCPM
Immune cell
- basophil: 171 nTPM
- plasmacytoid DC: 170 nTPM
- non-classical monocyte: 139 nTPM
- intermediate monocyte: 115 nTPM
- myeloid DC: 115 nTPM
- eosinophil: 106 nTPM
Brain region
- hypothalamus: 3,376 nTPM
- pons: 1,962 nTPM
- midbrain: 1,941 nTPM
- medulla oblongata: 1,482 nTPM
- thalamus: 1,411 nTPM
- cerebral cortex: 1,296 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GNAS.
Disease | AllUniProt
Conditions GNAS is implicated in, by any mechanism.
- ACTH-independent macronodular adrenal hyperplasia 1 (AIMAH1) MIM:219080
- Pseudohypoparathyroidism 1B (PHP1B) MIM:603233
- Pseudohypoparathyroidism 1C (PHP1C) MIM:612462
Disease | GeneticClinVar
238 pathogenic / likely-pathogenic of 1,309 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pseudohypoparathyroidism type I A
- GNAS-related disorder
- Pseudopseudohypoparathyroidism
- Pseudohypoparathyroidism
- Inborn genetic diseases
Disease | ImmuneIEDB
Conditions an epitope on GNAS was assayed in.
- type 1 diabetes mellitus T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.68
- gnomAD missense Z
- 2.65
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating dopamine receptor signaling pathway
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- bone development
- developmental growth
- platelet aggregation
- positive regulation of cold-induced thermogenesis
- sensory perception of chemical stimulus
Molecular functions
- adenylate cyclase activator activity
- beta-2 adrenergic receptor binding
- corticotropin-releasing hormone receptor 1 binding
- D1 dopamine receptor binding
- G protein activity
- G-protein beta/gamma-subunit complex binding
- GTP binding
- GTPase activity
- insulin-like growth factor receptor binding
- ionotropic glutamate receptor binding
- metal ion binding
- mu-type opioid receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GNAS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GNAS as an antibody target. Whether an autoantibody or antibody against GNAS could matter depends on whether native GNAS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GNAS is annotated at the cell surface, where native GNAS is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GNAS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...